Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond



Rating:

Share or cite this content

Citations should be made in the following way:
U. Falak (Newcastle Upon Tyne, United Kingdom), K. Lekhak (Newcastle Upon Tyne, United Kingdom), M. Athar (Newcastle Upon Tyne, United Kingdom), R. Crackett (Newcastle Upon Tyne, United Kingdom), J. Lordan (Newcastle Upon Tyne, United Kingdom), G. Macgowan (Newcastle Upon Tyne, United Kingdom), A. Fisher (Newcastle Upon Tyne, United Kingdom), A. Nair (Newcastle Upon Tyne, United Kingdom). Risk assessment in Pulmonary Arterial Hypertension (PAH) based on the Simplified French Model: A single centre experience. 3602

Member's Comments

No comment yet.

Related content which might interest you: The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH). Source: International Congress 2017 – PAH and CTEPH Year: 2017 Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital. Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Prognostic value of outcome variables at follow-up in patients with PAH Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial Source: Eur Respir J, 56 (4) 2000663; 10.1183/13993003.00663-2020 Year: 2020 Modified Desaturation Distance Ratio (mDDR) predicts prognosis in patients with Pulmonary Arterial Hypertension. Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 The phenotype of the Adult Mexican Patient with Pulmonary Arterial Hypertension: Baseline characteristics of the REMEHIP Registry. The REMEHIP Investigators. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Improvement of hypoxemia in patients affected by Pulmonary Arterial Hypertension (PAH) after a session of Controlled Breathing (CB) Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation Year: 2019 Does Wells score documentation really prevent excessive CTPA requests in a teaching hospital? A retrospective study in 800 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Long-term data from the Swiss pulmonary hypertension registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 An overview of thrombolytic treatment for pulmonary embolism: A single center experience Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018